ID: ALA1208994

Max Phase: Preclinical

Molecular Formula: C19H17NO3

Molecular Weight: 307.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NCCc1ccc(OC(=O)c2ccc3ccccc3c2)c(O)c1

Standard InChI:  InChI=1S/C19H17NO3/c20-10-9-13-5-8-18(17(21)11-13)23-19(22)16-7-6-14-3-1-2-4-15(14)12-16/h1-8,11-12,21H,9-10,20H2

Standard InChI Key:  IZZAHRDTHBVAOY-UHFFFAOYSA-N

Associated Targets(Human)

Dynamin-1 215 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 307.35Molecular Weight (Monoisotopic): 307.1208AlogP: 3.27#Rotatable Bonds: 4
Polar Surface Area: 72.55Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.39CX Basic pKa: 9.64CX LogP: 4.01CX LogD: 2.11
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.57Np Likeness Score: 0.29

References

1. Lee S, Jung KY, Park J, Cho JH, Kim YC, Chang S..  (2010)  Synthesis of potent chemical inhibitors of dynamin GTPase.,  20  (16): [PMID:20621477] [10.1016/j.bmcl.2010.06.092]

Source